A phase IIIb study to evaluate the efficacy and time course of treatment with SPD465 [amfetamine mixed salts; adderall] compared to placebo on simulated driving safety and performance in adults with attention-deficit hyperactivity disorder (ADHD)
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 12 Mar 2015
At a glance
- Drugs Mixed amfetamine salts (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Shire
- 16 Jul 2007 Status changed from initiated to withdrawn prior to recruitment.
- 18 Apr 2007 New trial record.